0001493152-26-006265.txt : 20260212 0001493152-26-006265.hdr.sgml : 20260212 20260211182703 ACCESSION NUMBER: 0001493152-26-006265 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 7 CONFORMED PERIOD OF REPORT: 20260211 FILED AS OF DATE: 20260212 DATE AS OF CHANGE: 20260211 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nasus Pharma Ltd CENTRAL INDEX KEY: 0002029039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 516022712 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42796 FILM NUMBER: 26622507 BUSINESS ADDRESS: STREET 1: 29 HARAKEVET ST CITY: TEL AVIV - YAFO STATE: L3 ZIP: 6618003 BUSINESS PHONE: 972 54-255-3956 MAIL ADDRESS: STREET 1: 29 HARAKEVET ST CITY: TEL AVIV - YAFO STATE: L3 ZIP: 6618003 6-K 1 form6-k.htm 6-K EX-4.1 2 ex4-1.htm EX-4.1 EX-10.1 3 ex10-1.htm EX-10.1 EX-10.2 4 ex10-2.htm EX-10.2 EX-10.3 5 ex10-3.htm EX-10.3 EX-99.1 6 ex99-1.htm EX-99.1 GRAPHIC 7 ex99-1_001.jpg GRAPHIC